This grant funds innovative medical education programs for healthcare professionals to address gaps in lupus, stroke prevention, and new immunomodulators for triple negative breast cancer.
Funder: Bristol Myers Squibb Foundation
Due Dates: June 1, 2026 (Systemic Lupus Erythematosus) | June 10, 2026 (Stroke prevention in AF and SSP) | June 12, 2026 (Novel and emerging immunomodulators for TNBC)
Funding Amounts: Up to $350,000 per grant; typically for single educational initiatives.
Summary: Supports development and delivery of innovative, independent medical education programs addressing current gaps for healthcare professionals in priority therapeutic areas.
The Bristol Myers Squibb Foundation’s Independent Medical Education (IME) Request for Education (RFE) program invites proposals to develop and implement educational initiatives for healthcare professionals. The program is designed to address independently verified educational needs in specific therapeutic areas, with new RFEs announced periodically throughout the year. Current open RFEs include topics such as systemic lupus erythematosus, stroke prevention in atrial fibrillation (AF) and secondary stroke prevention (SSP), and novel immunomodulators for triple negative breast cancer (TNBC). The aim is to close professional practice gaps and improve patient outcomes through evidence-based, interactive, and innovative educational programming.